Abstract
The reaction of aromatic and heteroaromatic aldehydes with 3-[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-one was studied. A series of new 5-(het)arylidene-3[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-ones was obtained. For synthesized compounds, antitumor and anti-inflammatory activity was studied. Hit-compounds were identified that exceeded the known comparison drugs in their action.
Similar content being viewed by others
REFERENCES
Xu, L.L., Zheng, C.J., Sun, L.P., Miao, J., and Piao, H.R., Eur. J. Med. Chem., 2012, vol. 48, p. 174. https://doi.org/10.4172/2161-0444.1000177
Jin, X., Zheng, C.J., Song, M.X., Wu, Y., Sun, L.P., Li, Y.J., Yu, L.J, and Piao, H.R., Eur. J. Med. Chem., 2012, vol. 56, p. 203. https://doi.org/10.2174/1874842201502010040
Zimenkovskii, B.S., Kutsyk, R.V., Lesyk, R.B., Matyichuk, V.S., Obushak, N.D., and Klyufinska, T.I., Pharm. Chem. J., 2006, vol. 40, no. 6, p. 303. https://doi.org/10.1007/s11094-006-0115-6
Sawaguchi, Y., Yamazaki, R., Nishiyama, Y., Sasai, T., Mae, M., Abe, A., Yaegashi, T., Nishiyama, H., and Matsuzaki, T., Anticancer Res., 2017, vol. 37, no. 8, p. 4051. https://doi.org/10.18632/oncotarget.3139
Vatolin, S., Phillips, J.G., Jha, B.K, Govindgari, S., Hu, J., Grabowski, D., Parker, Y., Lindner, D.J., Zhong, F., Distelhorst, C.W., Smith, M.R., Cotta, C., Xu, Y., Chilakala, S., Kuang, R.R., Tall, S., and Reu, F.J., Cancer Res., 2016, vol. 76, no. 11, p. 3340. https://doi.org/10.1158/0008-5472
Huang, M.J., Cheng, Y.C., Liu, C.R., Lin, S., and Liu, H.E., Exp. Hematol., 2006, vol. 34, no. 11, p. 1480. https://doi.org/10.3892/ol.2014.2277
Dago, C.D., N’ta Ambeu, C., Coulibaly, W.K., Békro, Y.A., Mamyrbekova-Bekro, J.A., Le Guével, R., Corlu, A., and Bazureau, J.P., Chem. Heterocycl. Compd., 2017, vol. 53, no. 3, p. 341. https://doi.org/10.1007/s10593-017-2056-2
Song, Y., Connor, D.T., Doubleday, R., Sorenson, R.J., Sercel, A.D. Unangst, P.S., Roth, B.D., Gilbertsen, R.B., Chan, K., Schrier, D.J., Guglietta, A., Bornemeier, D.A., and Dyer, R.D., J. Med. Chem., 1999, vol. 42, p. 1151. https://doi.org/10.1021/jm9805081
El-Miligy, M.M., Hazzaa, A.A., El-Messmary, H., Nassra, R.A., and El-Hawash, S.A.M., Bioorg. Chem. Lett., 2017, vol. 72, p. 102. https://doi.org/10.1016/j.bmcl.2016.10.022
Powers, J.P., Piper, D.E., Li, Y., Mayorga, V., Anzola, J., Chen, J.M., Jaen, J.C., Lee, G., Liu, J., Peterson, M.G., Tonn, G.R., Ye, O., Walker, N.P., and Wang, Z.J., J. Med. Chem., 2006, vol. 49, p. 1034. https://doi.org/10.1021/jm050859x
Lee, G., Piper, D.E., Wang, Z., Anzola, J., Powers, J., Walker, N., and Li, Y., J. Mol. Biol., 2006, vol. 357, p. 1051. https://doi.org/10.1016/j.jmb.2006.01.032
Talele, T.T., Arora, P., Kulkarni, S.S., Patel, M.R., Singh, S., Chudayeu, M., and Kaushik-Basu, N., Bioorg. Med. Chem., 2010, vol. 18, p. 4630. https://doi.org/10.1021/jm050855s
Ramirez, M.A. and Borja, N.L., Pharmacotherap., 2008, vol. 28, p. 646. https://doi.org/10.1592/phco.28.5.646
Bulic, B., Pickhardt, M., Khlistunova, I., Biernat, J., Mandelkow, E.M., Mandelkow, E., and Waldmann, H., Angew. Chem. Int. Ed., 2007, vol. 119, no. 48, p. 9375. https://doi.org/10.1002/ange.200704051
Tomasic, T. and Masic, L., Curr. Med. Chem., 2009, vol. 16, no. 13, p. 1596. https://doi.org/10.2174/092986709788186200
Kaminskyy, D., Kryshchyshyn, A., and Lesyk, R., Drug. Discov., 2017, vol. 12, no. 12, p. 1233. https://doi.org/10.1080/17460441
Kaminskyy, D., Kryshchyshyn, A., and Lesyk, R., Eur. J. Med. Chem., 2017, vol. 140, p. 542. https://doi.org/10.1016/j.ejmech.2017.09.031
Pokhodylo, N., Shyyka, O., and Matiychuk, V., Med. Chem. Res., 2014, vol. 23, no. 5, p. 2426. https://doi.org/10.1007/s00044-013-0841-8
Chaban, T., Klenina, O., Harkov, S., Ogurtsov, V., Chaban, I., and Nektegaev, I., Pharmacia, 2017, vol. 64, no. 4, p. 16.
Klenina, O., Chaban, T., Zimenkovsky, B., Harkov, S., Ogurtsov, V., Chaban, I., and Myrko, I., Pharmacia, 2017, vol. 64, no. 4, p. 49.
Chaban, T.I., Ogurtsov, V.V., Matiychuk, V.S., Chaban, I.G., Demchuk, I.L., and Nektegayev, I.A., Acta Chim. Slovenica, 2019, vol. 66, no. 1, p. 103. https://doi.org/10.17344/acsi.2018.4570
Pokhodylo, N.T., Savka, R.D., Matiichuk, V.S., and Obushak, N.D., Russ. J. Gen. Chem., 2009, vol. 79, no. 2, p. 309. https://doi.org/10.1134/S1070363209020248
Zelisko, N., Atamanyuk, D., Ostapiuk, Y., Bryhas, A., Matiychuk, V., Gzella, A., and Lesyk, R., Tetrahedron, 2015, vol. 71, no. 50, p. 9501. https://doi.org/10.1016/j.tet.2015.10.019
Chaban, T., Klenina, O., Chaban, I., Ogurtsov, V., Harkov, S., and Lelyukh, M., Pharmacia, 2018, vol. 65, no. 2, p. 54.
Zubkov, F.I., Ershova, J.D., Zaytsev, V.P., Obushak, M.D., Matiychuk, V.S., Sokolova, E.A., Khrustalev, V.N., and Varlamov, A.V., Tetrahedron Lett., 2010, vol. 51, no. 52, p. 6822. https://doi.org/10.1016/j.tetlet.2010.10.046
Pokhodylo, N.T., Matiychuk, V.S., and Obushak, M.D., Tetrahedron, 2009, vol. 65, no. 13, p. 2678. https://doi.org/10.1016/j.tet.2009.01.086
Chaban, T.I., Klenina, O.V., Zimenkovsky, B.S., Chaban, I.G., Ogurtsov, V.V., and Shelepeten, L.S., Der Pharma Chemica, 2016, vol. 8, no. 19, p. 534.
Matiichuk, V.S., Potopnyk, M.A., and Obushak, N.D., Russ. J. Org. Chem., 2008, vol. 44, no. 9, p. 1352. https://doi.org/10.1134/S1070428008090182
Chaban, T., Matiychuk, V., Ogurtsov, V., Chaban, I., Harkov, S., and Nektegaev, I., Pharmacia, 2018, vol. 65, no. 4, p. 51.
Zelisko, N., Atamanyuk, D., Vasylenko, O., Bryhas, A., Matiychuk, V., Gzella, A., and Lesyk, R., Tetrahedron, 2014, vol. 70, no. 3. Р. 720. https://doi.org/10.1016/j.tet.2013.11.083
Chaban, Z., Harkov, S., Chaban, T., Klenina, O., Ogurtsov, V., and Chaban, I., Pharmacia, 2017, vol. 64, no. 3, p. 52.
Gorak, Yu.I., Obushak, N.D., Matiichuk, V.S., and Lytvyn, R.Z., Russ. J. Org. Chem., 2009, vol. 45, no. 4, p. 541. https://doi.org/10.1134/S1070428009040125
Obushak, N.D., Lesyuk, A.I., Gorak, Y.I., and Matiichuk, V.S., Russ. J. Org. Chem., 2009, vol. 45, no. 9, p. 1375. https://doi.org/10.1134/S1070428009090103
Obushak, N.D., Gorak, Yu.I., Matiichuk, V.S., and Lytvyn, R.Z., Russ. J. Org. Chem., 2008, vol. 44, no. 11, p. 1689. https://doi.org/10.1134/S1070428008110213
Developmental Therapeutics Program. https://dtp.cancer.gov
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., and Vaigro-Wolff, A.J., Nat. Cancer Inst., 1991, vol. 83, p. 757. https://doi.org/10.1093/jnci/83
Boyd, M.R. and Paull, K.D., Drug Dev. Res. 1995, vol. 34, p. 91. https://doi.org/10.1002/ddr.430340203
Boyd, M.R. and Teicher, B.A., Humana Press., 1997, vol. 2, p. 23. https://doi.org/10.1007/s12028-015-0160-7
Shoemaker, R.H., Nature Rev. Cancer, 2006, vol. 6, p. 813. https://doi.org/10.11603/2312-0967
Pillai, A.D., Rathod, P.D., Franklin, P.X., Padh, H., Vasu, K.K., and Sudarsanam, V., Biochem. Biophys. Res. Commun., 2004, vol. 317, p. 1067. https://doi.org/10.1016/j.bbrc.2004.03.148
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Rights and permissions
About this article
Cite this article
Horishny, V.Y., Chaban, T.I. & Matiychuk, V.S. Synthesis of 5-(Het)arylidene-3-[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-one Derivatives and Study of Their Antitumor and Anti-Inflammatory Activity. Russ J Gen Chem 90, 1207–1215 (2020). https://doi.org/10.1134/S1070363220070063
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363220070063